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AbstrACt
Objective We aimed to evaluate the effects on depression 
scores of a lifestyle-focused cardiac support programme 
delivered via mobile phone text messaging among patients 
with coronary heart disease (CHD).
Design Substudy and secondary analysis of a parallel-
group, single-blind randomised controlled trial of patients 
with CHD.
setting A tertiary hospital in Sydney, Australia.
Intervention The Tobacco, Exercise and dieT MEssages 
programme comprised four text messages per week for 6 
months that provided education, motivation and support 
on diet, physical activity, general cardiac education and 
smoking, if relevant. The programme did not have any 
specific mental health component.
Outcomes Depression scores at 6 months measured 
using the Patient Health Questionnaire-9 (PHQ-9). 
Treatment effect across subgroups was measured using 
log-binomial regression model for the binary outcome 
(depressed/not depressed, where depressed is any score 
of PHQ-9 ≥5) with treatment, subgroup and treatment by 
subgroup interaction as fixed effects.
results Depression scores at 6 months were lower in 
the intervention group compared with the control group, 
mean difference 1.9 (95% CI 1.5 to 2.4, p<0.0001). 
The frequency of mild or greater depressive symptoms 
(PHQ-9 scores≥5) at 6 months was 21/333 (6.3%) in the 
intervention group and 86/350 (24.6%) in the control 
group (relative risk (RR) 0.26, 95% CI 0.16 to 0.40, 
p<0.001). This proportional reduction in depressive 
symptoms was similar across groups defined by age, sex, 
education, body mass index, physical activity, current 
smoking, current drinking and history of depression, 
diabetes and hypertension. In particular, the rates of PHQ-9 
≥5 among people with a history of depression were 4/44 
(9.1%) vs 29/62 (46.8%) in intervention vs control (RR 
0.19, 95% CI 0.07 to 0.51, p<0.001), and were 17/289 
(5.9%) vs 57/288 (19.8%) among others (RR 0.30, 95% CI 
0.18 to 0.50, p<0.001).
Conclusions Among people with CHD, a cardiac support 
programme delivered via mobile phone text messaging 
was associated with fewer symptoms of mild-to-moderate 
depression at 6 months in the treatment group compared 
with controls.
trial registration number ACTRN12611000161921.
IntrODuCtIOn  
Depression is common among patients with 
chronic diseases including coronary heart 
disease (CHD) and often under-recognised 
and untreated.1 Comorbid depression affects 
daily function and is associated with substan-
tial impairment in health-related quality of 
life and worse clinical outcomes in patients 
with CHD.2–4 As well as the direct negative 
impact of depression on the well-being of 
patients and their carers, depression after 
myocardial infarction is associated with 
substantially increased risk of cardiovascular 
and all-cause mortality.5 Patients with depres-
sion and CHD need effective treatment and 
support for both conditions. Attendance at 
cardiac rehabilitation following a cardiac 
event decreases morbidity, mortality, depres-
sive symptoms and improves quality of life.6 7 
Nevertheless, access to cardiac rehabilitation 
remains difficult, especially for those who are 
financially disadvantaged, part of an ethnic 
minority group, older or living far from health 
centres with limited access to transport.8 Also, 
research suggests some simple interventions 
delivered in the community/primary care 
can improve mental health outcomes and 
integrating treatments into chronic disease 
management improves outcomes.9 10 Inno-
vation is clearly needed to provide ongoing 
strengths and limitations of this study
 ► The strength of this trial is the parallel-group, pro-
spective, randomised controlled design.
 ► The trial had a relatively large sample size.
 ► With respect to limitations, it is a single-centre study.
 ► Depression was measured using the Patient Health 
Questionnaire-9 tool, which is designed as a screen-
ing tool.
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support for patients with cardiac and other chronic 
conditions, within limited healthcare resources.
In recent years, mobile phone technologies such as text 
messaging interventions comprising health education 
and reminders have shown promise in improving health-
care service delivery,11 increasing medication adherence12 
and improving primary prevention of cardiovascular 
disease, for example, improving glycaemic control 
among people with diabetes,13 and improving smoking 
quit rates.14 With respect to mental health, previous trials 
have reported that automated text messaging offered a 
feasible and acceptable means of monitoring depression 
and has the potential to improve outcomes in patients 
with comorbid depression.15 16 A systematic review of 6 
trials involving 577 participants with mental health disor-
ders (depression, alcohol dependence, schizophrenia 
and mood disorders) showed text messaging for health 
education, therapy goals and medication reminders inter-
ventions significantly improved several mental health-re-
lated outcomes in five studies including depression and 
quality of life scores.17 However, most of these were pilot 
studies and little is known about the extent to which text 
messaging might reduce depressive symptoms in people 
with CHD. We conducted the Tobacco, Exercise and dieT 
MEssages (TEXT ME) randomised controlled trial in 
patients with CHD that addressed multiple cardiovascular 
risk factors.18 The TEXT ME trial resulted in a modest 
improvement in low-density lipoprotein cholesterol level 
and greater improvement in other cardiovascular disease 
risk factors including blood pressure, body mass index, 
physical activity and smoking among patients with CHD.19 
The objective of this secondary and exploratory analysis 
of the TEXT ME study was to examine if the text message 
support programme had an impact on depressive symp-
toms at 6 months.
MethODs
study design
The current analyses were a prespecified secondary anal-
ysis of the TEXT ME trial.18 In brief, TEXT ME was a 
parallel-design, single-blind, randomised controlled clin-
ical trial enrolling 710 patients with CHD from a tertiary 
hospital in Sydney, Australia between September 2011 
and November 2013.19 The text messaging programme 
and its development process are detailed elsewhere.19
Participants
Potential participants were identified through screening 
daily admissions, coronary angiogram case lists and cardi-
ology outpatient clinic lists from a large tertiary care 
hospital which serves a diverse population in terms of 
ethnicity and socioeconomic status in the Western Sydney 
Local Health District, Sydney, Australia. We included 
patients older than 18 years, with documented CHD 
who were able to provide informed consent. CHD was 
defined as documented myocardial infarction, coronary 
artery bypass graft surgery or percutaneous coronary 
intervention, or proven angiographically and docu-
mented before consent. Patients were excluded if they 
did not have an active mobile phone, sufficient English 
language proficiency to read text messages or were 
referred for evaluation of congenital heart disease or 
coronary anomalies. Figure 1 displays the study flow chart. 
A total of 1301 patients with CHD were invited to partic-
ipate, 591 did not meet all inclusion criteria or declined 
to participate and 710 were randomised in TEXT ME.19 
Twenty-seven participants (including 12 who were unable 
to be contacted, 5 who died and 10 with missing data 
for depression symptoms at 6 months) were excluded 
from the analysis. Therefore, the current analyses were 
performed on 683 participants (96%).
Patient involvement
No patients were involved in the design of the study, 
recruitment and conduct of the study. However, during 
the process evaluation we shared the results of the study 
with the participants and collected feedback from the 
participants. The process evaluation focus group discus-
sions took place after participants completed the inter-
vention and follow-up visit.
randomisation, trial procedure and intervention
Randomisation was performed using a computerised 
randomisation programme through a secure web inter-
face. The random allocation sequence was in a uniform 
1:1 allocation ratio with a block size of 8 and was concealed 
from study personnel. After recruitment and discharge 
from hospital, if they were hospitalised, patients would 
receive a text message informing them of their allocation. 
Figure 1 Flow chart. PHQ-9, Patient Health 
Questionnaire-9.  
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Data were collected during face-to-face interviews using 
a structured questionnaire at baseline and 6 months by 
trained research assistants at the outpatient cardiology 
clinic of Westmead Hospital. At study entry, all interven-
tion participants were provided brief training on how to 
read, delete and save the text messages. Data entry was 
performed by study staff through entering data into the 
secure web interface. The web-based computer program 
was set to send messages to patients randomised to the 
intervention. The message programme development 
was based on behaviour change techniques linked to 
the theoretical framework reported by Abraham and 
Michie.20 21 In brief, it involved regular semi-personalised 
text messages providing advice, motivation and informa-
tion that aimed to improve general heart health, diet, 
physical activity and encourage smoking cessation (where 
relevant).22 Participants randomised to the intervention 
group received four text messages per week for 24 weeks. 
Participants received minimum information on depres-
sive symptoms being common in patients with CHD, and 
were advised to seek further help when needed, which is 
aligned with the curriculum of secondary prevention. For 
example, participants were encouraged to seek additional 
support “Not having support of family and friends can 
worsen heart disease—if you need help, do not be afraid 
to ask”. The design, development and samples of the text 
messages for TEXT ME have been described in a separate 
paper.22 Examples of text messages used in the TEXT ME 
are provided in online supplementary table S1.
Variables and outcomes
Data were collected on demographics, medical history 
and disease factors, including age, sex, years of education, 
current smoking and drinking status, history of diabetes, 
history of hypertension and history of depression. The 
history of depression included questions on prior treat-
ment with medicines, counselling or electroconvulsive 
therapy (ECT). Physical activity was assessed with the 
Global Physical Activity Questionnaire.23 Anthropometric 
measurements of weight, height, waist circumference and 
blood pressure were measured according to standardised 
procedures at baseline and at 6 months. Health-related 
quality of life was assessed using the 12 item Short Form 
(SF-12) questionnaire at baseline and 6 months.24
Depressive symptoms were assessed at 6 months using 
the 9-item Patient Health Questionnaire (PHQ-9). The 
questionnaire was only administered at the follow-up 
visit as there were concerns that assessment at base-
line while in hospital was not a true reflection of base-
line, and that repeating this questionnaire at two time 
points may impact responses. The PHQ-9 is a depression 
screening tool which generates a total score from 0 to 27. 
Scores are categorised as 0–4 no depression, 5–9 mild 
depression, 10–14 moderate depression, 15–19 moder-
ately severe depression and 20–27 severe depression.25 
The PHQ-9 has been shown to have reasonable sensi-
tivity (81.5) and specificity (80.6) at cut-off score ≥5 for 
patients with CHD25 and has been widely used to detect 
depression symptoms in clinical settings.26–28 The PHQ-9 
has shown good reliability (Cronbach’s α=0.89 and 0.86) 
and validity with similar tools used to screen for depres-
sion (ie, PHQ-9 was found to be highly correlated with 
scores on the Beck Depression Inventory in the general 
population, r=0.73).
Data analysis
Analyses were conducted on data using IBM SPSS V.20.0 
(IBM, USA) and SAS V.9.0 (SAS Institute, Cary, North 
Carolina, USA). The primary end point was the differ-
ence in PHQ-9 scores between intervention and control 
groups at 6 months. Baseline variables were summarised 
as frequency data, means and SD. The Shapiro-Wilk 
test of normality was used to evaluate distribution of 
the PHQ-9 scores. The mean difference in intervention 
and control group depression scores at 6 months were 
compared using an independent t-test, and between 
depression severity categories by Fisher’s exact test. The 
relative risks (RR) were reported with 95% CIs for group 
differences and in people with a history of depression. We 
conducted a post hoc analysis with PHQ-9 scores dichot-
omised at ≥5 representing mild symptoms of depression 
or greater. For the subgroup analysis, we performed a log 
binomial model for the binary outcome (depressed/not 
depressed, where depressed is any score of PHQ-9 ≥5) 
with treatment, subgroup and treatment by subgroup 
interaction as fixed effects. No baseline or any other 
covariates were included. All tests were two-sided and 
statistical significance was set at 0.05.
results
There were no significant differences in the baseline char-
acteristics of the 683 participants included in the analyses 
and the 27 who were excluded (figure 1).
The mean age of participants was 58±9 years, 18% were 
women. Sixteen per cent had a history of depression of 
whom 60% reported prior treatment with counselling, 
25% medication and 3% ECT. Almost two-thirds of the 
participants (62%) had history of hypertension and 
one-third (32%) had a history of diabetes. Baseline char-
acteristics were similar between the randomised groups 
(table 1).
effects of text messaging on depression
Depression scores at 6 months were significantly lower 
(better) in the intervention group compared with the 
control group, with a mean difference of 1.9 (95% CI 
1.5 to 2.4, p<0.0001) on the PHQ-9. There were signifi-
cantly fewer participants categorised as having mild, 
moderate, moderately severe and severe depression in 
the intervention group compared with the control group 
(p<0.001). The frequency of mild-to-moderate depressive 
symptoms (PHQ-9 scores 5–14) at 6 months was 6% in 
the intervention and 25% in the control group (RR 0.26, 
95% CI 0.16 to 0.40, p<0.001, unadjusted). The number 
of participants reporting any depression (PHQ-9 ≥5) was 
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significantly higher in the control group compared with 
the intervention group (86 vs 21) (table 2).
Table 3 reports the difference in the distribution of 
the PHQ-9 items at 6 months between the intervention 
and control groups. The magnitude of the differences 
between groups was fairly consistent for PHQ-9 items 1–7 
at 6 months. The frequency of participants endorsing 
PHQ-9 item 9 relating to suicidality was 0.6% in the inter-
vention group vs 0.9% in the control group (RR 0.70, 
95% CI 0.12 to 4.17, p=0.696) (table 3).
Figure 2 reports the treatment effect on PHQ-9 scores at 
6 months by patient subgroup. The RR of being depressed 
after treatment compared with not being treated was 
consistent across patient subgroups: age, sex, educa-
tion, body mass index, physical activity, current smoking, 
current drinking and history of depression, diabetes and 
hypertension (figure 2 and online supplementary table 
S2). The mental health component score of the SF-12 was 
significantly lower in the intervention group compared 
with the control group at 6 months (online supplemen-
tary table S3). The rates of PHQ-9 ≥5 among people with a 
history of depression were 4/44 (9.1%) vs 29/62 (46.8%) 
in intervention vs control (RR 0.19, 95% CI 0.07 to 0.51, 
p<0.001), and were 17/289 (5.9%) vs 57/288 (19.8%) 
among others (RR 0.30, 95% CI 0.18 to 0.50, p<0.001).
DIsCussIOn
In the TEXT ME trial, we found that a lifestyle-focused 
cardiovascular secondary prevention programme deliv-
ered via text message, and not specifically targeting 
depression or other abnormal mood symptoms, resulted 
in fewer symptoms of depression at 6 months in partic-
ipants receiving the texting intervention. There were 
75% fewer patients reporting PHQ-9 scores over 5 in 
the intervention group and this proportional reduction 
was similar across different patient groups and some-
what unexpected given the lack of therapeutic content 
provided in the intervention. This size of difference is 
consistent with one depressive symptom that occurred 
nearly every day now only occurring several days a week, 
or reducing from more than half the days of the week to 
not at all; or alternatively the cessation of two symptoms 
that previously occurred several days a week.
A recent systematic review assessing the impact of text 
messaging interventions in individuals with mental health 
disorders suggested that the interventions might be effec-
tive in improving mental health outcomes  (Box 1).17 
However, the evidence for mHealth interventions in 
lowering depressive symptoms in patients with CHD, or in 
patients with other chronic health conditions is limited. 
The Care Assessment Platform for Cardiac Rehabilita-
tion29 smart-phone-based intervention conducted in 120 
patients with postmyocardial infarction, in 2009, included 
a comprehensive package of health and exercise moni-
toring, motivational and educational material delivery 
via text messaging and weekly mentoring consultations. 
Table 2 Depression scores (PHQ-9) at 6 months
Variables
Intervention (n=333)
n (%)
Control (n=350)
n (%)
Mean difference 
(95% CI) P values
PHQ-9 total score, mean (SD) 1.0 (2.2) 2.9 (3.3) 1.9 (1.5 to 2.4) <0.0001*
No depression (score 0–4) 312 (93.7) 264 (75.4)
Mild depression (score 5–9) 16 (4.8) 68 (19.4)
Moderate depression (score 10–14) 4 (1.2) 16 (4.6)
Moderately severe (score 15–19) 1 (0.3) 1 (0.3)
Severe depression (score 20–27) 0 (0) 1 (0.3)
Any depression (score 5–27) 21 (6.3) 86 (24.6) <0.001†
*Independent t-test.
†Fisher’s exact test.
PHQ-9, Patient Health Questionnaire-9.
Table 1 Baseline characteristics of the study participants
Characteristics
Intervention 
group (n=333)
n (%)
Control group
(n=350) n (%)
Age, mean (SD) years 57.9 (9.0) 57.3 (9.2)
Women 61 (18.3) 61 (17.4)
Education, mean (SD), years 11.4 (3.5) 11.5 (3.5)
Body mass index, kg/m2 
mean (SD)
29.7 (6.0) 29.6 (5.9)
Physical activity—regular 
exercise
32 (9.6) 35 (10.0)
Current drinker 86 (25.8) 116 (33.1)
Current smoker 174 (52.3) 189 (54.0)
History of diabetes 105 (31.5) 114 (32.6)
History of hypertension 212 (63.7) 212 (60.6)
History of depression 44 (13.2) 62 (17.7)
  Prior medication 14/44 (31.8) 13/62 (21.0)
  Prior psychological 
counselling
25/44 (56.8) 41/62 (66.1)
  Prior electroconvulsive 
therapy
3/44 (6.8) 0/62 (0.0)
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It demonstrated non-significant reductions in psycholog-
ical distress at 6 weeks (measured by Kessler 10 Psycholog-
ical Distress Scale30, mean difference 1.85, 95% CI −0.11 
to 3.8, p=0.1 and DASS-depression score, mean differ-
ence 0.90, 95% CI −0.77 to 2.57, p=0.3). Attendance in 
cardiac rehabilitation programmes have been shown to 
be associated with decreased symptoms of depression, 
and improved psychological well-being.31 Internet-based 
cognitive behavioural therapy support programmes have 
also been shown to have potential in reducing depressive 
symptoms.32 33 With increasing use of mobile phones, 
text messaging has the potential to support cardiac 
Table 3 Difference in PHQ-9 items at 6 months
Variables
Intervention
(n=333) n (%)
Control (n=350)
n (%) P values
PHQ-9 item 1: little interest or pleasure in doing things 26 (7.8) 85 (24.3) <0.001
PHQ-9 item 2: feeling down, depressed or hopeless 43 (12.9) 132 (37.7) <0.001
PHQ-9 item 3: trouble falling or staying asleep, or sleeping too much 44 (13.2) 119 (34.0) <0.001
PHQ-9 item 4: feeling tired or having little energy 67 (20.1) 187 (53.4) <0.001
PHQ-9 item 5: poor appetite or overeating 25 (7.5) 60 (17.1) <0.001
PHQ-9 item 6: feeling bad about yourself—or that you are a failure or 
have let yourself or your family down
17 (5.1) 35 (10.0) 0.016
PHQ-9 item 7: trouble concentrating on things, such as reading the 
newspaper or watching television
10 (3.0) 23 (6.6) 0.030
PHQ-9 item 8: moving or speaking so slowly that other people could 
have noticed? Or so fidgety or restless that you have been moving a 
lot more than usual
4 (1.2) 8 (2.3) 0.281
PHQ-9 item 9: thoughts that you would be better off dead, or 
thoughts of hurting yourself in some way
2 (0.6) 3 (0.9) 0.694
PHQ-9 item 9 relating to suicidality.
PHQ-9, Patient Health Questionnaire-9. 
Figure 2 Treatment effects on  Patient Health Questionnaire-9 scores ≥5 at 6 months, by patient subgroup. BMI, body mass 
index; RR, relative risk.
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rehabilitation and reduce the burden of cardiovascular 
diseases and depression.34
In addition to the main effects on clinical outcomes 
of TEXT ME,19 the additional benefit of TEXT ME in 
reducing depressive symptoms at 6 months make it a very 
appealing low-cost strategy for patients with CHD. Depres-
sion is associated with worse health outcomes in patients 
with CHD.35 36 Poor health behaviours, such as smoking, 
non-adherence to prescribed medications and lifestyle 
changes are observed in patients with depression.37 
Previous studies have suggested association of depression 
with quality of life.38 In our trial, quality of life—mental 
component summary scores were significantly lower in the 
intervention group compared with control group. These 
results should be interpreted cautiously because medica-
tion use can be a marker of depression, and our trial did 
not collect information on dose and duration of medica-
tion use for depression. It is possible that the improve-
ments in behavioural risk factors in TEXT ME may have 
been in part mediated by improvements in psychological 
well-being. From our qualitative evaluation,21 partici-
pants in TEXT ME felt supported and engaged, and this 
is likely to contribute to the mechanisms that explain 
the reduction in depressive symptoms. It is also possible 
that the focus on improving lifestyle behaviours in TEXT 
ME contributed to differences in depressive symptoms 
as maintaining a healthy lifestyle is a key component of 
many depression management programmes.39
The strengths of this trial is the parallel-group, prospec-
tive, randomised controlled design and a relatively large 
sample size. With respect to limitations, it is a single-centre 
study, and the findings need to be replicated in other centres 
and populations. The analysis is a substudy and secondary 
analysis of the main TEXT ME trial and baseline measures 
of PHQ-9 were not included. The PHQ-9 was designed as a 
screening tool for depression and depressive symptoms. We 
did not confirm the presence of depression in trial partic-
ipants using the gold standard semi-structured psychiatric 
interview. However, self-reported depression scores are 
highly correlated with the diagnosis of clinical depression 
and the PHQ-9 ≥5 cut point has good sensitivity (82%) 
and specificity (81%) when used with patients with CHD.26 
While we did not assess depressive symptoms at baseline, 
randomisation ensured that most patient characteristics 
were distributed evenly between groups.
A previous study in Denmark, of 19 520 patients with acute 
coronary syndrome reported the prevalence of depression 
15%–20%.40 A meta-analysis in patients with heart disease 
reported that the risk of mortality was two times higher 
in people with a history of depression.38 Our trial showed 
that the prevalence of depressive symptoms was lower in 
the intervention group compared with the control group 
among those with a history of depression. While depres-
sion is recognised as important to manage in patients with 
chronic disease, there are few mechanisms available to help 
prevent the development of depression in patients at risk. 
The findings of this studysuggest the exciting potential of 
a simple and potentially scalable text message-based inter-
vention to reduce mild-to-moderate depressive symptoms in 
this population. Addressing depressive symptoms early may 
be key to supporting patients in achieving multiple changes 
in risk factor behaviour .
In summary, this study demonstrates that provision of a 
text message-based intervention focused on lifestyle change 
among people with CHD was associated with a significantly 
lower frequency of  mild-to-moderate depression symp-
toms at 6 months in the intervention group compared with 
controls. These results suggest that text messaging might 
be a low-cost and scalable intervention to prevent the 
development of depression in patients with cardiovascular 
diseases. Further research is needed to determine whether 
a text messaging programme can prevent the development 
of depression in patients with CHD.
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box 1 Panel: research in context
systematic review
Systematic reviews of randomised controlled studies of mobile phone 
technologies for health behaviour change and disease management 
suggest that text messaging interventions might be useful for self-man-
agement of chronic diseases.11 Another systematic review of seven 
studies measuring the impact of text messaging in mental health re-
ported that five studies had significant improvements in a variety of 
psychiatric and social functioning assessments.17 These studies sug-
gest mobile phone text messaging programme has potential to support 
management of patients with mental illness.
Interpretation
The results of the TEXT ME trial suggest that provision of a text mes-
sage-based intervention focused on lifestyle change among people 
with coronary heart disease was associated with less mild-to-moder-
ate depressive symptoms at 6 months. These results suggest that text 
messaging might be a low-cost and scalable intervention to address 
the development of depression in patients with cardiovascular diseases.
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